リンコサミド系薬
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2013/10/29 17:36:24」(JST)
[Wiki en表示]
Clindamycin. (Note extra chlorine compared to lincomycin, but disregard inversion of image.)
Lincosamides (e.g. lincomycin, clindamycin) are a class of antibiotics.
Contents
- 1 Mechanism of action
- 2 History and uses
- 3 Resistance
- 4 Formulation
- 5 Pharmacodynamics
- 6 Further reading
- 7 References
Mechanism of action[edit]
Lincosamides prevent bacteria replicating by interfering with the synthesis of proteins. They bind to the 23s portion of the 50S subunit of bacterial ribosomes and cause premature dissociation of the peptidyl-tRNA from the ribosome.[1] Lincosamides do not interfere with protein synthesis in human cells (or those of other eukaryotes) because human ribosomes are structurally different from those of bacteria.
History and uses[edit]
The first lincosamide to be discovered is lincomycin, isolated from Streptomyces lincolnensis in a soil sample from Lincoln, Nebraska (hence the bacterial name).
Lincomycin has been superseded by clindamycin, which exhibits improved antibacterial activity. Clindamycin also exhibits some activity against parasitic protozoa, and has been used in toxoplasmosis and malaria.
They are normally used to treat staphylococci and streptococci, and have proved useful in treating Bacteroides fragilis and some other anaerobes. They are used in the treatment of Toxic Shock Syndrome and thought to directly block the M protein production that leads to the severe inflammatory response.
Lincosamide antibiotics are one of the classes of antibiotics most associated with pseudomembranous colitis caused by C. difficile.[2]
Resistance[edit]
Target bacteria may alter the drug's binding site (similar to resistance found in macrolides and streptogramins). The resistance mechanism is methylation of the 23s binding site. If this occurs then the bacteria are resistant to both the macrolides and the lincosamides. Also, enzymatic inactivation of clindamycin has been described (rare).
Formulation[edit]
The lincosamides, as the hydrochloride salt, are bitter to taste, so for oral formulation they are given as the palmitate esters, or formulated in capsules. Clindamycin is given intravenously as clindamycin phosphate, which is then converted into active clindamycin within the body.
Pharmacodynamics[edit]
These are bacteriostatic drugs and antagonists of macrolides and streptogramins.
Further reading[edit]
- Van Bambeke F. Mechanisms of action. In Armstrong D, Cohen J. Infectious diseases. Mosby, London, 1999, pp7/1.1-7/1.14
References[edit]
- ^ The Mechanism of Action of Macrolides, Lincosamides and Streptogramin B Reveals the Nascent Peptide Exit Path in the Ribosome Martin Lovmar and Måns Ehrenberg
- ^ http://www.nlm.nih.gov/medlineplus/ency/article/000259.htm.
Antibacterials: protein synthesis inhibitors (J01A, J01B, J01F, J01G, QJ01XQ)
|
|
30S |
Aminoglycosides
(initiation inhibitors) |
-mycin (Streptomyces) |
- Streptomycin#
- Dihydrostreptomycin
- Neomycin#
- Framycetin
- Paromomycin
- Ribostamycin
- Kanamycin#
- Amikacin
- Arbekacin
- Bekanamycin
- Dibekacin
- Tobramycin
- Spectinomycin#
- Hygromycin B
|
|
-micin (Micromonospora) |
- Gentamicin#
- Netilmicin
- Sisomicin
- Isepamicin
|
|
|
Tetracycline antibiotics
(tRNA binding) |
Tetracyclines |
- Doxycycline#
- Chlortetracycline
- Clomocycline
- Demeclocycline
- Lymecycline
- Meclocycline
- Metacycline
- Minocycline
- Oxytetracycline
- Penimepicycline
- Rolitetracycline
- Tetracycline
|
|
Glycylcyclines |
|
|
|
|
50S |
Oxazolidinone
(initiation inhibitors) |
- Linezolid
- Torezolid
- Eperezolid
- Posizolid
- Radezolid
- Ranbezolid
- Sutezolid
|
|
Peptidyl transferase |
Amphenicols |
- Chloramphenicol#
- Azidamfenicol
- Thiamphenicol
- Florfenicol
|
|
Pleuromutilins |
- Retapamulin
- Tiamulin
- Valnemulin
|
|
|
MLS (transpeptidation/translocation) |
Macrolides |
- Azithromycin#
- Clarithromycin
- Dirithromycin
- Erythromycin#
- Flurithromycin
- Josamycin
- Midecamycin
- Miocamycin
- Oleandomycin
- Rokitamycin
- Roxithromycin
- Spiramycin
- Troleandomycin
- Tylosin
- Ketolides
- Telithromycin
- Cethromycin
- Solithromycin†
|
|
Lincosamides |
- Clindamycin#
- Lincomycin
- Pirlimycin
|
|
Streptogramins |
- Pristinamycin
- Quinupristin/dalfopristin
- Virginiamycin
|
|
|
|
EF-G |
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
gr+f/gr+a (t)/gr-p (c)/gr-o
|
drug (J1p, w, n, m, vacc)
|
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Biofilm formation and antimicrobial resistance genes of coagulase-negative staphylococci isolated from cows with mastitis in Argentina.
- Srednik ME1, Tremblay YD2, Labrie J2, Archambault M2,3, Jacques M2,3,4, Alicia FC5, Gentilini ER6.
- FEMS microbiology letters.FEMS Microbiol Lett.2017 Jan 12. pii: fnx001. doi: 10.1093/femsle/fnx001. [Epub ahead of print]
- Mastitis affects the health and welfare of dairy cows worldwide. Coagulase-negative staphylococci (CNS) are known to form biofilms and are increasingly recognized as a cause of persistent bovine intramammary infections. A total of 90 CNS isolated from cows with clinical and subclinical mastitis in A
- PMID 28087612
- A Novel erm(44) Gene Variant from a Human Staphylococcus saprophyticus Isolate Confers Resistance to Macrolides and Lincosamides but Not Streptogramins.
- Strauss C1, Hu Y2, Coates A2, Perreten V3.
- Antimicrobial agents and chemotherapy.Antimicrob Agents Chemother.2016 Dec 27;61(1). pii: e01655-16. doi: 10.1128/AAC.01655-16. Print 2017 Jan.
- A novel erm(44) gene variant, erm(44)v, has been identified by whole-genome sequencing in a Staphylococcus saprophyticus isolate from the skin of a healthy person. It has the particularity to confer resistance to macrolides and lincosamides but not to streptogramin B when expressed in S. aureus The
- PMID 27799208
- Antibiotics in Endodontics: a review.
- Segura-Egea JJ1, Gould K2, Şen BH3, Jonasson P4, Cotti E5, Mazzoni A6, Sunay H7, Tjäderhane L8,9, Dummer PM10.
- International endodontic journal.Int Endod J.2016 Dec 22. doi: 10.1111/iej.12741. [Epub ahead of print]
- The overuse of antibiotics and the emergence of antibiotic-resistant bacterial strains is a global concern. This concern is also of importance in terms of the oral microbiota and the use of antibiotics to deal with oral and dental infections. The aim of this paper was to review the current literatur
- PMID 28005295
Japanese Journal
- 長野県諏訪地域における抗菌薬使用量と耐性菌の検出頻度について
- 具 芳明
- 保健医療科学 60(5), 431-432, 2011-10-00
- … MLS (macrolides, lincosamides, and streptogramins) was the most prescribed drug group, followed by beta-lactams other than penicillin and quinolone. …
- NAID 110009585556
- Phenotypic Differentiation of Macrolide Resistance among Streptococcus pneumoniae Carrying mefA and/or ermB Genes
- Kaieda Satoru,Yano Hisakazu,Okitsu Naohiro,Hosaka Yoshio,Okamoto Ryoichi,Inoue Matsuhisa,Takahashi Haruo
- Acta medica Nagasakiensia 49(1/2), 19-24, 2004-06-00
- … Of the other 40 isolates, 25 carried the ermB gene and 15 carried the both mefA and ermB genes, all of them showed high resistance to clindamycin (MIC?128 μg/mL) and were resistant to macrolides, lincosamides and streptogramin B (MLSB resistance phenotype). …
- NAID 110000939710
- Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci
Related Links
- General Properties Lincosamides are derivatives of an amino acid and a sulfur-containing octose. They are monobasic and more stable in salt forms (hydrochlorides and phosphates). Antimicrobial Activity Mode of Action Lincomycin ...
- Mechanism of action [edit source | edit] Lincosamides prevent bacteria replicating by interfering with the synthesis of proteins. They bind to the 23s portion of the 50S subunit of bacterial ribosomes and cause premature dissociation of ...
Related Pictures
★リンクテーブル★
[★]
- 英
- lincosamides, lincosamide drugs
- 関
- リンコマイシン。リンコサミド
[show details]